首页 > 技能座谈 > 正文
肿瘤与蛋白质组学
主页:188体育平台网址 发布时间:2019-11-06    

时间:2019年11月8日(周五)中午12点30分

地点:卫津路园区管理层学问运动中心多功能厅

报告题目:肿瘤与蛋白质组学

主讲人:陈瑞冰

【个人概况】

陈瑞冰,188体育官网药物科技与技能企业导员。2005年毕业于北京企业生物与分子工程企业获得硕士学历。2009年毕业于美国威斯康星企业麦迪逊分企业获硕士学历。主要研讨方向是肿瘤蛋白质组学。曾获天津市“131”人力第二层次、天津市少年研讨优秀人力、天津市少年人力托举工程等人力称号。目前已发表SCI收录技能作文四十篇,其中第一/通讯编辑作文21篇,多篇作文发表在组学领域全球高水平期刊Nucleic Acids Research和 Molecular & Cellular Proteomics上。作为项目负责人主持国内要点研发计划子课题及国内自然科技基金面上项目等4项国内级项目,并主持天津市自然科技基金等省部级研讨项目5项。现任中国质谱协会理事,及多个全球期刊审稿人。

【报告内容概况】

癌症是来源于上皮细胞的恶性肿瘤,是严重影响人类安康的重大疾病。与正常细胞相比,肿瘤细胞获得了一部列特殊的生物学特性,例如持续增殖的能力、抗凋亡、激活血管生成、向周边单位浸润及发生转移。这些特性与肿瘤细胞内部生命过程的变化密不可分,这包括基因组的不稳定性、细胞代谢的改变以及炎症等等。蛋白质组学是近二十年快速发展起来的分子生物学检测技能,是高通量、定性、定量检测蛋白质分子及其生物修饰的重要方法,为大家了解肿瘤发生发展的调控机制、寻找新的治疗肿瘤的有效手段提供了必要手段。本报告将先容癌症的生物学特征,简述调控肿瘤进展的重要生理过程,进而先容蛋白质组学技能的发展及其在探索肿瘤发生发展机制及临床诊疗方面的应用和研讨进展。

【相关科室】生命科技、医学、生物

【主办单位】校工会、自习室、中科院、校少年导员联谊会

Lecture: Cancer and Proteomics

When: 12:30 p.m., Friday, November, 8th, 2019

Where: Multifunctional Hall, Cultural Activity Center for Faculty and Staff, Weijin Road Campus

Lecturer: Ruibing Chen

Ruibing Chen is a Professor at School of Pharmaceutical Science and Technology of Tianjin University. She graduated from Peking University in 2005, and obtained her PhD in Analytical Chemistry from University of Wisconsin at Madison in 2009. Research in her laboratory is focused on developing and implementing proteomics strategies to gain new insights into the molecular mechanisms regulating tumor development and progression. She has published 40 peer-reviewed scientific papers in top journals in the area of proteomics. She is now a committee member of the Chinese Society for Mass Spectrometry, and she serves as a reviewer for many international journals.

About the Lecture:

When normal cells evolve progressively to a neoplastic state, they acquire a succession of many hallmark capabilities, such as sustaining proliferative signaling, evading growth suppressors, resisting cell death, activating invasion and metastasis, etc. To better understand cancer biology is crucial to discover novel therapeutic anti-cancer strategies. Herein, I will firstly introduce these hallmarks of cancer, and then highlight the current progress in proteomics, and how we use proteomics strategies to study the mechanism and clinical phenotypes of cancer.

Relevant Discipline: life science, medical science, chemistry

Organizers: Trade Unions, Library, Office of Science and Technology, Young Teachers Association

All students and staff of Tianjin University are welcome.

XML 地图 | Sitemap 地图